Array BioPharma

Array BioPharma
TypeSubsidiary
Nasdaq: ARRY
IndustryOncology
Medication
Founded1998; 28 years ago (1998)
Founder
  • Drs. Tony Piscopio
  • Kevin Koch
  • David Snitman
  • K.C. Nicolaou
Headquarters,
United States
Revenue$173.8 million (2018)
ParentPfizer
Websitewww.arraybiopharma.com

Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is currently a subsidiary of Pfizer after being acquired for $11 billion in 2019.

History

In 1998, the company was founded by Drs. Tony Piscopio, Kevin Koch, David Snitman, and K.C. Nicolaou.

In November 2000, the company became a public company via an initial public offering.

In June 2019, Pfizer acquired the company for approximately $11 billion.

Discovery of FDA Approved Small Molecules